Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu S;Vernieri C;Di Maio M;Marconcini R;Spada F;Massironi S;Ibrahim T;Brizzi MP;Campana D;Faggiano A;Giuffrida D;Rinzivillo M;Cingarlini S;Aroldi F;Antonuzzo L;Berardi R;Catena L;De Divitiis C;Ermacora P;Perfetti V;Fontana A;Razzore P;Carnaghi C;Davì MV;Cauchi C;Duro M;Ricci S;Fazio N;Cavalcoli F;Bongiovanni A;La Salvia A;Brighi N;Colao A;Puliafito I;Panzuto F;Ortolani S;Zaniboni A;Di Costanzo F;Torniai M;Bajetta E;Tafuto S;Garattini SK;Femia D;Prinzi N;Concas L;Lo Russo G;Milione M;Giacomelli L;Buzzoni R;Delle Fave G;Mazzaferro V;de Braud F

2018-01-01